TVTX - Company ID 0001438533
As of 2026-11-06, Travere Therapeutics, Inc. (TVTX) has a market capitalization of $4.63 B, making it the #1459 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $4.63 B |
| 2026-11-05 | $4.77 B |
| 2026-11-04 | $4.87 B |
| 2026-11-03 | $4.59 B |
| 2026-11-02 | $4.80 B |
| 2026-11-01 | $4.69 B |
| 2026-10-31 | $4.69 B |
| 2026-10-30 | $4.69 B |
| 2026-10-29 | $4.70 B |
| 2026-10-28 | $4.73 B |
| 2026-10-27 | $4.73 B |
| 2026-10-26 | $4.59 B |
As of 2026-11-06, Travere Therapeutics, Inc. (TVTX) has a market capitalization of $4.63 B, making it the #1459 most valuable US-listed company.
Travere Therapeutics, Inc. is the #1459 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $4.66 B |
| 2026-10-24 | $4.66 B |
| 2026-10-23 | $4.66 B |
| 2026-10-22 | $4.88 B |
| 2026-10-21 | $4.94 B |
| 2026-10-20 | $4.88 B |
| 2026-10-19 | $4.70 B |
| 2026-10-18 | $4.61 B |
| 2026-10-17 | $4.61 B |
| 2026-10-16 | $4.69 B |
| 2026-10-15 | $4.91 B |
| 2026-10-14 | $4.99 B |
| 2026-10-13 | $4.83 B |
| 2026-10-12 | $4.84 B |
| 2026-10-11 | $4.85 B |
| 2026-10-10 | $4.85 B |
| 2026-10-09 | $4.85 B |
| 2026-10-08 | $4.84 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.